These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10391824)

  • 1. Plasmapheresis in thyrotoxicosis.
    Ligtenberg J; Tulleken J; Zijlstra J
    Ann Intern Med; 1999 Jul; 131(1):71-2. PubMed ID: 10391824
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis.
    Diamond TH; Rajagopal R; Ganda K; Manoharan A; Luk A
    Intern Med J; 2004 Jun; 34(6):369-70; author reply 370-1. PubMed ID: 15228405
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.
    Aghini-Lombardi F; Mariotti S; Fosella PV; Grasso L; Pinchera A; Braverman LE; Martino E
    J Endocrinol Invest; 1993 Nov; 16(10):823-6. PubMed ID: 8144857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amiodarone-induced thyrotoxicosis].
    Bogazzi F; Tomisti L; Di Bello V; Martino E
    G Ital Cardiol (Rome); 2017 Mar; 18(3):219-229. PubMed ID: 28398380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-induced thyrotoxicosis.
    Daniels GH
    J Clin Endocrinol Metab; 2001 Jan; 86(1):3-8. PubMed ID: 11231968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amiodarone-induced thyrotoxicosis].
    Kaufmann C; Cron TA; Meier C; Staub JJ; Oberholzer M; Osswald S
    Schweiz Med Wochenschr; 2000 Oct; 130(43):1610-7. PubMed ID: 11100515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Thyroidectomy for Amiodarone-induced Thyrotoxicosis in the Hyperthyroid State.
    Kaderli RM; Fahrner R; Christ ER; Stettler C; Fuhrer J; Martinelli M; Vogt A; Seiler CA
    Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):45-8. PubMed ID: 26575117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report.
    Yamamoto J; Dostmohamed H; Schacter I; Ariano RE; Houston DS; Lewis B; Knoll C; Katz P; Zarychanski R
    J Clin Apher; 2014 Jun; 29(3):168-70. PubMed ID: 24265247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone-induced thyrotoxicosis: not a benign condition.
    Leung PM; Quinn ND; Belchetz PE
    Int J Clin Pract; 2002; 56(1):44-6. PubMed ID: 11831834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.
    Uzzan B; Pussard E; Leon A; Bekhechi D; Krivitzky A; Modigliani E; Perret G; Vassy R; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1991 Mar; 31(3):371-2. PubMed ID: 2054281
    [No Abstract]   [Full Text] [Related]  

  • 12. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone and the thyroid].
    Martino E; Bartalena L; Bogazzi F; Brogioni S; Aghini-Lombardi F; Manetti L; Tanda ML
    Cardiologia; 1995 Dec; 40(12 Suppl 1):173-8. PubMed ID: 8998711
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of severe amiodarone-induced thyrotoxicosis after failure of standard medical treatment].
    Mateo Gavira I; Vilchez López F; Larrán Escandón L; Roldán Caballero P; Aguilar Diosdado M
    Endocrinol Nutr; 2013 Dec; 60(10):e43-5. PubMed ID: 23540613
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyrotoxicosis and the cardiovascular system.
    Roffi M; Cattaneo F; Brandle M
    Minerva Endocrinol; 2005 Jun; 30(2):47-58. PubMed ID: 15988401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperthyroidism--differential diagnosis and differential therapy].
    Henzen Ch
    Praxis (Bern 1994); 2003 Jan; 92(1-2):18-24. PubMed ID: 12577605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.
    Sato K; Omi Y; Kodama H; Obara T; Yamazaki K; Yamada E; Seki T; Takano K; Shiga T; Kasanuki H
    Intern Med; 2008; 47(8):757-62. PubMed ID: 18421194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?
    Ryan LE; Braverman LE; Cooper DS; Ladenson PW; Kloos RT
    Thyroid; 2004 Feb; 14(2):149-53. PubMed ID: 15068630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiodarone and the thyroid].
    Lahera Vargas M; de Luis Román D; Hervilla Ezquerra S; Maldonado Castro G; Zurita Sepúlveda P
    Rev Clin Esp; 1999 Apr; 199(4):227-32. PubMed ID: 10364796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.